What are examples of clinical audit topics related to coronary angiography and angioplasty?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Audit Topics for Coronary Angiography and Angioplasty

Clinical audits in coronary angiography and angioplasty should focus on appropriateness of indications, procedural quality metrics, patient outcomes, and system efficiency to directly impact morbidity, mortality, and quality of life.

Based on the ACC/AHA guidelines 1 and contemporary practice standards 2, 3, here are specific audit topics organized by clinical priority:

Process and Appropriateness Audits

Indication Appropriateness

  • Audit adherence to Class I, II, and III indications for coronary angiography across different clinical scenarios (stable angina, unstable coronary syndromes, post-MI risk stratification, preoperative evaluation) 1
  • Review appropriateness of angiography timing in STEMI patients (door-to-balloon times, primary PCI vs. thrombolysis decisions) 1
  • Evaluate use of non-invasive testing prior to angiography in stable patients to ensure proper risk stratification 1
  • Assess frequency of "normal" coronary angiograms in STEMI presentations and alternative diagnoses identified 4

Pre-procedural Risk Assessment

  • Audit calculation and documentation of STS risk scores for patients being considered for CABG 2
  • Review SYNTAX score utilization in multivessel disease decision-making, acknowledging interobserver variability limitations 2
  • Evaluate renal insufficiency screening and contrast nephropathy prevention protocols 1

Technical Quality Audits

Procedural Technique

  • Measure reproducibility and interobserver variability in angiographic interpretation 1
  • Audit completeness of angiographic reports including all desired elements (vessel dimensions, stenosis severity, collaterals, left ventricular function) 1
  • Review use of adjunctive imaging (IVUS, intravascular Doppler, coronary angioscopy) and their appropriateness 1
  • Assess vascular access site selection and complication rates 3

Restenosis and Follow-up

  • Track angiographic and clinical restenosis rates after PCI, particularly comparing BMS vs. DES outcomes 1, 3
  • Audit post-revascularization ischemia evaluation and management 1

Outcome Audits

Complications and Safety

  • Monitor procedural complication rates including emergency surgery, subacute closure, renal insufficiency, vascular complications 1
  • Track periprocedural enzyme elevation (CK levels) after catheter-based revascularization 1
  • Evaluate no-reflow and slow-flow phenomena management 3
  • Assess mortality rates for emergency PTCA and emergency bypass surgery 1

Patient-Centered Outcomes

  • Measure survival rates post-procedure, stratified by ejection fraction and clinical presentation 1
  • Audit return to employment rates post-revascularization 1
  • Track quality of life improvements in angina reduction and functional capacity 3

System Efficiency Audits

Resource Utilization

  • Evaluate appropriateness of outpatient vs. inpatient procedures based on patient selection criteria 5
  • Audit discharge planning effectiveness from cardiology clinics, measuring discharge rates and follow-up appropriateness 6
  • Review regional variation in coronary angiography utilization rates 1
  • Assess cost-effectiveness comparing stress testing pathways vs. direct angiography 1

Workflow Optimization

  • Measure time from stress test to angiography when indicated 1
  • Audit ad hoc vs. staged angioplasty decision-making and outcomes 3
  • Track unplanned hospitalizations after intended outpatient procedures 5

Special Population Audits

High-Risk Groups

  • Evaluate outcomes in diabetic patients with multivessel disease (PCI vs. CABG decisions) 2
  • Audit elderly patient outcomes and complication rates 1
  • Review management of patients with left main stenosis and complexity stratification 2
  • Assess outcomes in patients with systolic dysfunction or hibernating myocardium 1

Specific Clinical Scenarios

  • Audit management of cardiac arrest survivors and sudden death survivors 1
  • Review perioperative evaluation for noncardiac surgery patients 1
  • Evaluate congenital heart disease patients undergoing angiography 1

Documentation and Reporting Audits

  • Assess completeness of angiographic reports including vessel dimensions, stenosis quantification, collateral assessment, and left ventricular function 1
  • Review documentation of informed consent and discussion of risks/benefits
  • Audit adherence to CAD-RADS 2.0 reporting standards for standardized communication 7

Common Pitfalls to Avoid

When conducting these audits, avoid:

  • Auditing Class III indications without context - some may be appropriate in specific circumstances
  • Focusing solely on volume metrics without assessing appropriateness and outcomes
  • Ignoring interobserver variability in angiographic interpretation, which can significantly affect audit results 1
  • Failing to stratify by patient complexity when comparing outcomes across operators or institutions

The most impactful audits will be those that directly link process measures to patient outcomes (mortality, MI rates, repeat revascularization) rather than simply measuring adherence to documentation standards.

References

Research

Discharge planning in a cardiology out-patient clinic: a clinical audit.

International journal of health care quality assurance, 2014

Research

Coronary computed tomography angiography for clinical practice.

Japanese journal of radiology, 2024

Related Questions

Does a patient need a driver after a coronary computed tomography angiography (CTA) with contrast?
What does CAD-RADS 2/P1/HRP (Coronary CT angiography report indicating mild stenosis, primarily non-calcified plaque with high‑risk features) mean?
Is it appropriate to order a coronary computed tomography angiography (CTA) for a patient presenting with syncope?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
What benefits are seen with escitalopram?
What is the recommended treatment regimen for Vibrio vulnificus infection, including appropriate antibiotics, dosing, duration, and management of severe cases?
What are the DSM-5 criteria for Dependent Personality Disorder?
What is the evidence‑based dosing regimen for β‑lactam antibiotics in adult septic patients undergoing haemodialysis or peritoneal dialysis?
What antibiotic regimen is appropriate for a leg wound with extensive tissue exposure and green (Pseudomonas) exudate?
Given bilateral hip X‑ray showing mild degenerative changes with chondrocalcinosis consistent with calcium pyrophosphate deposition disease, moderate degenerative changes of the symphysis pubis and lower lumbar spine unchanged since [date], and a DEXA scan indicating osteopenia (T‑score –1.6) with severe bilateral hip pain, what management recommendations are appropriate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.